レポートナンバー 0000040950
22カ国におけるラテンアメリカのがん診断市場（2025年）：2024年の国別のサプライヤーのシェアと戦略、40を超える個別の腫瘍マーカーの2024〜2029年の販売量と売上セグメントの予測
VPGMarketResearch
2025 Latin America Cancer Diagnostics Market in 22 Countries--2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
発刊日
2025/01/21
言語英語
体裁PDF
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
レポート概要
この独自のレポートは、2024年の国別のサプライヤー戦略とシェア、主要腫瘍マーカーの2024年から2029年の販売量と売上予測など、他の公開情報源からは入手できない情報と分析を提供します。このレポートは、検査別に新しい技術や製品を開発またはマーケティングしている企業の包括的なリストも提供します。
このレポートはセクションごとに提供されており、特定の情報ニーズや予算に合わせてカスタマイズできます。
ACTH、AFP、ベータ-2 ミクログロブリン、CA 15-3/27.29、CA 19-9、CA 125、カルシトニン、カテプシン、CEA、クロモグラニン、結腸特異的抗原、サイトケラチン、エストロゲン受容体、フェリチン、ガストリン、HCG、インスリン、インターフェロン、インターロイキン、リンパ球サブタイピング、ニューロン特異的エノラーゼ、核小体、潜血、がん遺伝子、膵臓がん胎児性抗原、パプスメア、副甲状腺ホルモン、プロゲステロン受容体、前立腺酸性ホスファターゼ、前立腺特異抗原、S-100タンパク質、セロトニン、シアル酸、扁平上皮がん抗原、TDT、チミジンキナーゼ、サイログロブリン、組織ポリペプチド抗原など
国
-
アルゼンチン、ボリビア、ブラジル、チリ、コロンビア、コスタリカ、キューバ、ドミニカ共和国、エクアドル、エルサルバドル、グアテマラ、ハイチ、ホンジュラス、ジャマイカ、メキシコ、ニカラグア、パナマ、パラグアイ、ペルー、プエルトリコ、ウルグアイ、ベネズエラ
調査企業
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- DiaSorin
- 栄研化学（Eiken Chemical）
- Elitech Group
- Enzo Biochem
- 富士レビオ（Fujirebio）
- 富士フイルム和光純薬（Fujifilm Wako）
- Grifols
- Hologic
- Leica Biosystems
- PerkinElmer
- Qiagen
- QuidelOrtho
- Roche
- Siemens Healthineers
- タカラバイオ（Takara Bio）
- Thermo Fisher
レポート詳細
目次
List of Tables
Argentina Cancer Diagnostic Volume Forecasts by Test
Argentina Cancer Diagnostics Sales Forecasts by Test
Bolivia Cancer Diagnostic Volume Forecasts by Test
Bolivia Cancer Diagnostics Sales Forecasts by Test
Brazil Cancer Diagnostic Volume Forecasts by Test
Brazil Cancer Diagnostics Sales Forecasts by Test
Chile Cancer Diagnostic Volume Forecasts by Test
Chile Cancer Diagnostics Sales Forecasts by Test
Colombia Cancer Diagnostic Volume Forecasts by Test
Colombia Cancer Diagnostics Sales Forecasts by Test
Costa Rica Cancer Diagnostic Volume Forecasts by Test
Costa Rica Cancer Diagnostics Sales Forecasts by Test
Cuba Cancer Diagnostic Volume Forecasts by Test
Cuba Cancer Diagnostics Sales Forecasts by Test
Dominican Republic Cancer Diagnostic Volume Forecasts by Test
Dominican Republic Cancer Diagnostics Sales Forecasts by Test
Ecuador Cancer Diagnostic Volume Forecasts by Test
Ecuador Cancer Diagnostics Sales Forecasts by Test
El Salvador Cancer Diagnostic Volume Forecasts by Test
El Salvador Cancer Diagnostics Sales Forecasts by Test
Guatemala Cancer Diagnostic Volume Forecasts by Test
Guatemala Cancer Diagnostics Sales Forecasts by Test
Haiti Cancer Diagnostic Volume Forecasts by Test
Haiti Cancer Diagnostics Sales Forecasts by Test
Honduras Cancer Diagnostic Volume Forecasts by Test
Honduras Cancer Diagnostics Sales Forecasts by Test
Jamaica Cancer Diagnostic Volume Forecasts by Test
Jamaica Cancer Diagnostics Sales Forecasts by Test
Mexico Cancer Diagnostic Volume Forecasts by Test
Mexico Cancer Diagnostics Sales Forecasts by Test
Nicaragua Cancer Diagnostic Volume Forecasts by Test
Nicaragua Cancer Diagnostics Sales Forecasts by Test
Panama Cancer Diagnostic Volume Forecasts by Test
Panama Cancer Diagnostics Sales Forecasts by Test
Paraguay Cancer Diagnostic Volume Forecasts by Test
Paraguay Cancer Diagnostics Sales Forecasts by Test
Peru Cancer Diagnostic Volume Forecasts by Test
Peru Cancer Diagnostics Sales Forecasts by Test
Puerto Rico Cancer Diagnostic Volume Forecasts by Test
Puerto Rico Cancer Diagnostics Sales Forecasts by Test
Uruguay Cancer Diagnostic Volume Forecasts by Test
Uruguay Cancer Diagnostics Sales Forecasts by Test
Venezuela Cancer Diagnostic Volume Forecasts by Test
Venezuela Cancer Diagnostics Sales Forecasts by Test
Tumor Marker Classification
Major Companies Developing or
Marketing ACTH Tests
Major Companies Developing or
Marketing AFP Tests
Major Companies Developing or
Marketing Beta-2 Microglobulin Tests
Major Companies Developing or
Marketing CA 15-3/27.29 Tests
Major Companies Developing or
Marketing CA 19-9 Tests
Major Companies Developing or
Marketing CA 125 Tests
Major Companies Developing or
Marketing Calcitonin Tests
Major Companies Developing or
Marketing CEA Tests
Major Companies Developing or
Marketing Estrogen Receptor Tests
Major Companies Developing or
Marketing Progesterone Receptor Tests
Major Companies Developing or
Marketing Ferritin Tests
Major Companies Developing or
Marketing Gastrin Tests
Major Companies Developing or
Marketing HCG Tests
Major Companies Developing or
Marketing Insulin Tests
Major Companies Developing or
Marketing NSE Tests
Major Companies Developing or
Marketing Occult Blood Tests
Major Companies Developing or
Marketing PAP Smear/HPV Tests
Major Companies Developing or
Marketing PAP Tests
Major Companies Developing or
Marketing PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or
Marketing Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
in Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
